SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sam who wrote (2468)10/24/1997 11:32:00 AM
From: Joe E.  Read Replies (3) of 6136
 
Re Dr. Gallo's chemokines:

Another far-off in the future treatment for AIDS. Pray that it works.

Has essentially no longterm investment impact on AGPH, IMO, as Viracept should by then have been supplanted as one of the leading treatments for the disease. AGPH by then should have a stable of drugs, much like Merck (well, maybe smaller).

May provide a short term buying opportunity, if it gets sufficient media attention this weekend.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext